IAIN J WEBB, M.D.
Osteopathic Medicine in Boston, MA

License number
Massachusetts 77369
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
20 Fayette St Apt #2, Boston, MA 02116
Phone
(617) 448-4168

Personal information

See more information about IAIN J WEBB at radaris.com
Name
Address
Phone
Iain Webb
20 Fayette St #2, Boston, MA 02116
Iain Webb, age 61
20 Fayette St APT 1, Boston, MA 02116
Iain G Webb, age 61
20 Fayette St, Boston, MA 02116
(617) 482-7833
Iain G Webb, age 64
60 Rutland St, Boston, MA 02118
(617) 437-9870

Professional information

Iain Webb Photo 1

At Millennium: The Takeda Oncology Company

Position:
Senior Medical Director, Global Medical Affairs at Millennium: The Takeda Oncology Company
Location:
Greater Boston Area
Industry:
Pharmaceuticals
Work:
Millennium: The Takeda Oncology Company since Feb 2011 - Senior Medical Director, Global Medical Affairs Millennium: The Takeda Oncology Company Oct 2001 - Feb 2011 - Senior Medical Director, Oncology Clinical Research Dana-Farber Cancer Institute 1995 - 2001 - Attending Physician
Education:
Harvard Medical School 1993 - 1995
McGill University 1988 - 1993
University of Toronto 1987 - 1988
McGill University 1982 - 1987
MD, Medicine


Iain J Webb Photo 2

Dr. Iain J Webb, Boston MA - MD (Doctor of Medicine)

Specialties:
Oncology, Medical Oncology
Address:
44 Binney St, Boston 02115
(617) 632-2251 (Phone), (617) 632-2251 (Fax)
Certifications:
Internal Medicine, 1991, Medical Oncology, 2005
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
44 Binney St, Boston 02115
Brigham and Women's Hospital
75 Francis St, Boston 02115
Education:
Medical School
McGill University / Faculty of Medicine
St Michaels Hosp
Montreal Gen Hosp
Beth Israel Deaconess Medical Center
McGill U


Iain Webb Photo 3

Modified Antibodies To Prostate-Specific Membrane Antigen And Uses Thereof

US Patent:
2006006, Mar 23, 2006
Filed:
Sep 2, 2005
Appl. No.:
11/218813
Inventors:
Iain Webb - Boston MA, US
Christopher Horvath - Taunton MA, US
International Classification:
A61K 39/395
US Classification:
424155100
Abstract:
Modified antibodies, or antigen-binding fragments thereof, to the extracellular domain of human prostate specific membrane antigen (PSMA) are provided. The modified anti-PSMA antibodies, or antigen-binding fragments thereof, have been rendered less immunogenic compared to their unmodified counterparts to a given species, e.g., a human. Pharmaceutical compositions including the aforesaid antibodies, nucleic acids, recombinant expression vectors and host cells for making such antibodies and fragments are also disclosed. Methods of using the antibodies of the invention to detect human PSMA, or to ablate or kill a PSMA-expressing cell, e.g., a PSMA-expressing cancer or prostatic cell, either in vitro or in vivo, are also provided.